vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and VIRTUS INVESTMENT PARTNERS, INC. (VRTS). Click either name above to swap in a different company.
VIRTUS INVESTMENT PARTNERS, INC. is the larger business by last-quarter revenue ($208.0M vs $123.8M, roughly 1.7× NATURES SUNSHINE PRODUCTS INC). VIRTUS INVESTMENT PARTNERS, INC. runs the higher net margin — 16.3% vs 3.3%, a 13.0% gap on every dollar of revenue. On growth, NATURES SUNSHINE PRODUCTS INC posted the faster year-over-year revenue change (4.7% vs -10.9%). NATURES SUNSHINE PRODUCTS INC produced more free cash flow last quarter ($7.6M vs $-74.1M). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs -3.2%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
VIRTUS INVESTMENT PARTNERS, INC.VRTSEarnings & Financial Report
Virtus Investment Partners, Inc. is an American company which operates as a multi-manager asset management business, comprising a number of individual affiliated managers, each having its own investment process and brand, and the services of unaffiliated sub advisers.
NATR vs VRTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $208.0M |
| Net Profit | $4.1M | $33.9M |
| Gross Margin | 72.5% | — |
| Operating Margin | 4.3% | 19.1% |
| Net Margin | 3.3% | 16.3% |
| Revenue YoY | 4.7% | -10.9% |
| Net Profit YoY | 1379.4% | -14.2% |
| EPS (diluted) | $0.23 | $5.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $208.0M | ||
| Q3 25 | $128.3M | $216.4M | ||
| Q2 25 | $114.8M | $210.5M | ||
| Q1 25 | $113.2M | $217.9M | ||
| Q4 24 | $118.2M | $233.5M | ||
| Q3 24 | $114.6M | $227.0M | ||
| Q2 24 | $110.6M | $224.4M | ||
| Q1 24 | $111.0M | $222.0M |
| Q4 25 | $4.1M | $33.9M | ||
| Q3 25 | $5.3M | $31.3M | ||
| Q2 25 | $5.3M | $42.7M | ||
| Q1 25 | $4.7M | $28.1M | ||
| Q4 24 | $-321.0K | $39.5M | ||
| Q3 24 | $4.3M | $49.1M | ||
| Q2 24 | $1.3M | $26.0M | ||
| Q1 24 | $2.3M | $37.9M |
| Q4 25 | 72.5% | — | ||
| Q3 25 | 73.3% | — | ||
| Q2 25 | 71.7% | — | ||
| Q1 25 | 72.1% | — | ||
| Q4 24 | 72.0% | — | ||
| Q3 24 | 71.3% | — | ||
| Q2 24 | 71.4% | — | ||
| Q1 24 | 71.2% | — |
| Q4 25 | 4.3% | 19.1% | ||
| Q3 25 | 7.0% | 21.7% | ||
| Q2 25 | 3.7% | 21.5% | ||
| Q1 25 | 5.4% | 16.8% | ||
| Q4 24 | 3.8% | 21.7% | ||
| Q3 24 | 4.6% | 24.3% | ||
| Q2 24 | 5.1% | 19.7% | ||
| Q1 24 | 4.2% | 14.5% |
| Q4 25 | 3.3% | 16.3% | ||
| Q3 25 | 4.2% | 14.5% | ||
| Q2 25 | 4.6% | 20.3% | ||
| Q1 25 | 4.2% | 12.9% | ||
| Q4 24 | -0.3% | 16.9% | ||
| Q3 24 | 3.8% | 21.6% | ||
| Q2 24 | 1.2% | 11.6% | ||
| Q1 24 | 2.1% | 17.1% |
| Q4 25 | $0.23 | $5.15 | ||
| Q3 25 | $0.30 | $4.65 | ||
| Q2 25 | $0.28 | $6.12 | ||
| Q1 25 | $0.25 | $4.05 | ||
| Q4 24 | $-0.02 | $4.65 | ||
| Q3 24 | $0.23 | $5.71 | ||
| Q2 24 | $0.07 | $2.43 | ||
| Q1 24 | $0.12 | $4.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | — |
| Total DebtLower is stronger | — | $390.0M |
| Stockholders' EquityBook value | $161.6M | $934.0M |
| Total Assets | $261.1M | $4.3B |
| Debt / EquityLower = less leverage | — | 0.42× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | — | ||
| Q3 25 | $95.6M | — | ||
| Q2 25 | $81.3M | — | ||
| Q1 25 | $86.5M | — | ||
| Q4 24 | $84.7M | — | ||
| Q3 24 | $78.7M | — | ||
| Q2 24 | $68.7M | — | ||
| Q1 24 | $77.8M | — |
| Q4 25 | — | $390.0M | ||
| Q3 25 | — | $390.6M | ||
| Q2 25 | — | $231.3M | ||
| Q1 25 | — | $231.7M | ||
| Q4 24 | — | $232.1M | ||
| Q3 24 | — | $237.5M | ||
| Q2 24 | — | $247.6M | ||
| Q1 24 | $2.1M | $253.0M |
| Q4 25 | $161.6M | $934.0M | ||
| Q3 25 | $166.7M | $918.7M | ||
| Q2 25 | $163.7M | $896.4M | ||
| Q1 25 | $167.1M | $893.7M | ||
| Q4 24 | $161.0M | $897.5M | ||
| Q3 24 | $162.6M | $889.0M | ||
| Q2 24 | $156.4M | $868.7M | ||
| Q1 24 | $159.7M | $871.7M |
| Q4 25 | $261.1M | $4.3B | ||
| Q3 25 | $264.8M | $3.9B | ||
| Q2 25 | $254.9M | $3.7B | ||
| Q1 25 | $252.7M | $3.7B | ||
| Q4 24 | $240.9M | $4.0B | ||
| Q3 24 | $245.3M | $3.6B | ||
| Q2 24 | $235.8M | $3.6B | ||
| Q1 24 | $247.3M | $3.5B |
| Q4 25 | — | 0.42× | ||
| Q3 25 | — | 0.43× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | — | 0.26× | ||
| Q4 24 | — | 0.26× | ||
| Q3 24 | — | 0.27× | ||
| Q2 24 | — | 0.29× | ||
| Q1 24 | 0.01× | 0.29× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $-67.2M |
| Free Cash FlowOCF − Capex | $7.6M | $-74.1M |
| FCF MarginFCF / Revenue | 6.1% | -35.6% |
| Capex IntensityCapex / Revenue | 1.9% | 3.3% |
| Cash ConversionOCF / Net Profit | 2.41× | -1.99× |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $100.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $-67.2M | ||
| Q3 25 | $18.5M | $108.3M | ||
| Q2 25 | $4.3M | $75.8M | ||
| Q1 25 | $2.6M | $-3.8M | ||
| Q4 24 | $12.2M | $1.8M | ||
| Q3 24 | $9.6M | $69.1M | ||
| Q2 24 | $1.3M | $70.0M | ||
| Q1 24 | $2.2M | $-34.5M |
| Q4 25 | $7.6M | $-74.1M | ||
| Q3 25 | $16.8M | $106.9M | ||
| Q2 25 | $3.0M | $74.2M | ||
| Q1 25 | $1.5M | $-6.8M | ||
| Q4 24 | $10.0M | $-3.8M | ||
| Q3 24 | $7.9M | $68.7M | ||
| Q2 24 | $-2.0M | $68.6M | ||
| Q1 24 | $-1.5M | $-36.5M |
| Q4 25 | 6.1% | -35.6% | ||
| Q3 25 | 13.1% | 49.4% | ||
| Q2 25 | 2.6% | 35.2% | ||
| Q1 25 | 1.3% | -3.1% | ||
| Q4 24 | 8.5% | -1.6% | ||
| Q3 24 | 6.9% | 30.3% | ||
| Q2 24 | -1.9% | 30.6% | ||
| Q1 24 | -1.4% | -16.4% |
| Q4 25 | 1.9% | 3.3% | ||
| Q3 25 | 1.3% | 0.7% | ||
| Q2 25 | 1.2% | 0.7% | ||
| Q1 25 | 1.0% | 1.4% | ||
| Q4 24 | 1.9% | 2.4% | ||
| Q3 24 | 1.5% | 0.2% | ||
| Q2 24 | 3.0% | 0.6% | ||
| Q1 24 | 3.3% | 0.9% |
| Q4 25 | 2.41× | -1.99× | ||
| Q3 25 | 3.46× | 3.45× | ||
| Q2 25 | 0.81× | 1.77× | ||
| Q1 25 | 0.55× | -0.13× | ||
| Q4 24 | — | 0.04× | ||
| Q3 24 | 2.21× | 1.41× | ||
| Q2 24 | 0.97× | 2.69× | ||
| Q1 24 | 0.94× | -0.91× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
VRTS
| Open End Funds | $68.9M | 33% |
| Retail Separate Accounts | $51.3M | 25% |
| Institutional Accounts | $39.6M | 19% |
| Administration And Shareholder Service Fees | $18.4M | 9% |
| Closed End Funds | $15.9M | 8% |
| Distribution And Service Fees | $12.3M | 6% |
